Cabot Corp. (NYSE:CBT) announced this week that Cabot Specialty Fluids has been recognized for its sustainable business model at this year's United Nations International Development Organization (UNIDO) chemical leasing awards. UNIDO is devoted to reducing unnecessary consumption of finite chemical resources and the awards are an integral part of UNIDO's Green Industry Initiative. More than a decade ago, Cabot broke with traditional oil field chemical sales models by pioneering the leasing of its cesium formate drilling and completion fluids. With this model, Cabot retains ownership and stewardship of the chemicals at all times and charges customers for the number of days they are used in the field. At the end of the project, the fluids are returned for reclamation and leased out for the next job.
Cabot Corporation provides specialty chemicals and performance materials worldwide. The company Core segment manufactures carbon black and elastomer composite products for tire applications; and tantalum, niobium, and their alloys for producing superalloys and chemical process equipment, as well as for use in other industrial and aerospace applications.
Enzo Biochem, Inc. (NYSE:ENZ)
ENZ was founded in 1976 and is headquartered in New York, New York. Enzo Biochem, Inc. is a life sciences and biotechnology company that engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. ENZ operates in three segments: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. The Enzo Life Sciences segment manufactures, develops, and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers. It offers products applied in the fields of antibiotics, autophagy, cancer, cell cycle, cell death, cell signaling, cell trafficking, genomics/molecular biology, immunology, inflammation, lipid signaling, neurobiology, protein degradation, ROS/RNS, and stress/heat shock.
To learn more about ENZ visit: http://www.enzo.com
Semgroup Corporation Class A Co (NYSE:SEMG) announced it will celebrate the company’s listing on the New York Stock Exchange with the traditional ceremony of ringing the The Opening BellSM in New York City on Friday, December 17 at 9:00 a.m. ET. Cecil Mooreland, the terminal manager for SemCrude, L.P. in Cushing, OK, representing all SemGroup employees, and John Chlebowski, SemGroup’s Chairman of the Board of Directors, will jointly ring The Opening Bell. “Our employees have worked so hard over this last year and together we have achieved this great milestone.
SemGroup Corporation, through its subsidiaries, purchases, sells, processes, transports, and stores crude oil, natural gas, natural gas liquids, asphalt, and refined products through a network of pipelines, terminals, and storage tanks in the United States, Canada, Mexico, and the United Kingdom.
Power3 Medical Products, Inc. (OTC:PWRM)
After skin cancer, breast cancer is the most common malignancy recognized in females across the nation. Nevertheless, breast cancer levels have lowered in recent years, despite the fact that healthcare doctors are not specific about why. For lots of ladies, breast melanoma is actually the disease they fear the most.
Alzheimer's ultimately declines. Alzheimer's is a progressing sickness, in which symptoms gradually worsen over a period of time. Continuing memory loss is minor, but with late-stage Alzheimer's, people will not be able to hold a conversation and respond to their natural environment. Alzheimer's is the 6th major cause of death in the USA. Some people who have Alzheimer's live life an average of eight years after their indications come to be noticeable to other people, but survival can range from 3 to 20 years, based on maturity and various health conditions.
Alzheimer's is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer's is the reason for 50 to 70 percent of dementia cases.
PWRM has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. PWRM recently filed several patent applications that are currently pending for its NuroPro technology. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM was founded in 1992 and is based in The Woodlands, Texas.
To learn more about PWRM visit: http://www.Power3Medical.com
Caterpillar Inc. (NYSE:CAT) announced several changes at the officer level, including the initial leadership for the integration of Bucyrus International. The company is also announcing the completion of organizational changes that will position Caterpillar to deliver on its Vision 2020 strategy. After more than 41 years with Caterpillar, Jim Parker, vice president, Americas Distribution Division, has elected to retire effective January 1, 2011. "During the course of his career at Caterpillar, Jim has consistently taken a passionate, customer-focused approach to leadership, and has worked very closely with our dealers, including key support for several dealer transitions in recent years," said Stu Levenick, Caterpillar group president with responsibility for Customer & Dealer Support. "We thank Jim for his leadership, dedication and long service and wish him all the best in the next phase of life.
Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, and industrial gas turbines worldwide. Its Machinery business engages in the design, manufacture, marketing, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).